Detection of liver metastases: gadobenate dimeglumine-enhanced three-dimensional dynamic phases and one-hour delayed phase MR imaging versus superparamagnetic iron oxide-enhanced MR imaging
- 29 December 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in European Radiology
- Vol. 15 (2), 220-228
- https://doi.org/10.1007/s00330-004-2570-3
Abstract
The aim of this study was to compare the diagnostic performance of gadobenate dimeglumine (Gd-BOPTA)-enhanced MR imaging, including dynamic phases and one-hour delayed phase, versus superparamagnetic iron oxide (SPIO)-enhanced imaging for detection of liver metastases. Twenty-three patients with 59 liver metastases underwent Gd-BOPTA-enhanced MR imaging (unenhanced, arterial, portal, equilibrium and one-hour delayed phase) using three-dimensional volumetric interpolated imaging and SPIO-enhanced T2-weighted turbo spin–echo and T2*-weighted gradient-echo sequences on a 1.5-T unit. Three observers independently interpreted the three sets of images, i.e. Gd-BOPTA-enhanced dynamic MRI (set 1), delayed phase imaging (set 2) and SPIO-enhanced MRI (set 3). Diagnostic accuracy was evaluated using the alternative-free response receiver operating chracteristic (ROC) analysis. Sensitivity and positive predictive value were also evaluated. The mean accuracy (Az values) and sensitivity of Gd-BOPTA-enhanced delayed phase imaging (0.982, 95.5%) were comparable to those of SPIO-enhanced imaging (0.984, 97.2%). In addition, Az values and sensitivities of both imaging sets were significantly higher than those of Gd-BOPTA-enhanced dynamic images (0.826, 77.4%: p<0.05). There was no significant difference in the positive predictive value among the three image sets. Gd-BOPTA-enhanced delayed phase imaging showed comparable diagnostic performance to SPIO-enhanced imaging for the detection of liver metastases, and had a better diagnostic performance than Gd-BOPTA-enhanced dynamic images.Keywords
This publication has 32 references indexed in Scilit:
- Surgical treatment of liver metastases by radiofrequency ablation, resection, or in combinationEuropean Journal of Surgical Oncology, 2004
- Percutaneous radiofrequency ablation of liver metastases in potential candidates for resectionCancer, 2003
- Evaluation of the Accuracy of Gadobenate Dimeglumine-Enhanced MR Imaging in the Detection and Characterization of Focal Liver LesionsAmerican Journal of Roentgenology, 2000
- Comparison of unenhanced, hepatic arterial-dominant, and portal venous-dominant phase helical CT for the detection of liver metastases in women with breast carcinoma.American Journal of Roentgenology, 1999
- Gadobenate Dimeglumine (Gd-BOPTA)Investigative Radiology, 1998
- Gadolinium Chelates with Weak Binding to Serum ProteinsInvestigative Radiology, 1997
- Technical Note. Do Arterial Phase Helical CT Images Improve Detection or Characterization of Colorectal Liver Metastases?Journal of Computer Assisted Tomography, 1997
- Comparison of gadolinium chelates with manganese-DPDP for liver lesion detection and characterization: Preliminary resultsMagnetic Resonance Imaging, 1996
- Gadobenate dimeglumine--a new contrast agent for MR imaging: preliminary evaluation in healthy volunteers.American Journal of Roentgenology, 1992
- Iron oxide-enhanced MR imaging of the liver and spleen: review of the first 5 years.American Journal of Roentgenology, 1990